Cefixime Versus Benzathine Penicillin G for Early Syphilis Treatment

This clinical trial is investigating whether a new antibiotic treatment, cefixime, is as effective and safe as the current standard treatment, benzathine penicillin G, for early syphilis. Syphilis is a sexually transmitted infection that needs timely and effective treatment to prevent complications. The study is important because it could provide a new treatment option for people who cannot receive penicillin, either due to allergies or because the injection is not available. It could also offer an oral alternative, making treatment easier in situations where injections are not practical. Participants in the study will be randomly assigned to receive either cefixime or benzathine penicillin G. Cefixime is taken orally, while benzathine penicillin G is given as an injection. The study will compare the effectiveness of these treatments in curing early syphilis and will monitor safety measures to ensure that the new treatment does not cause significant side effects. The goal is to see if cefixime can perform as well as the current standard treatment, potentially providing more flexibility in managing syphilis treatment. The study does not list specific primary outcomes, but it will focus on evaluating the efficacy and safety of the treatments.